Retraction

Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression

Citations (17)

17
Total Citations
8
Post-Retraction
(47.1%)
9
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
7 Within 1 year
0 After 2+ years
381 Days since retraction (latest)
MicroRNA-383: A tumor suppressor miRNA in human cancer
Abdollah Jafarzadeh, Majid Noori, Shaghayegh Sarrafzadeh et al. (10 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: Oct 2022
27 citations
381 days after retraction
Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC)
Lijuan Zhang, Xinyi Cai, Youguo Dai et al. (6 authors)
BioMed Research International Open Access
Published: Jul 2022
2 citations
282 days after retraction
Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical <i>In Vivo</i> Models of Esophageal Squamous Cell Cancer
Ulrich H. Weidle, Adam Nopora
Anticancer Research Open Access
Published: Jul 2022
1 citation
277 days after retraction
LncRNA FGD5‐AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR‐223 and regulating the expression of ECT2 and FAT1
Chen‐Kun He, Zeng‐Bo Li, Da Yi et al. (8 authors)
Hepatology Research
Published: Apr 2022
10 citations
187 days after retraction
A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response
Uttam Sharma, Masang Murmu, Tushar Singh Barwal et al. (9 authors)
Current Oncology Open Access
Published: Mar 2022
13 citations
180 days after retraction
GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway
Jingyang Chen, Meiru Bian, Lingxiao Pan et al. (5 authors)
Journal of Oncology Open Access
Published: Mar 2022
7 citations
172 days after retraction
lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes
Xiao-ling Fang, Shu-guang Shi
Human & Experimental Toxicology
Published: Jan 2022
4 citations
96 days after retraction
A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis
Yi Qian, Wei Xie, Wei Sun et al. (5 authors)
Journal of Cancer Open Access
Published: Dec 2021
14 citations
79 days after retraction
Long Non-Coding RNA FGD5-AS1 Induced by Chlamydia trachomatis Infection Inhibits Apoptosis via Wnt/β-Catenin Signaling Pathway
Yating Wen, Fangzhen Luo, Lanhua Zhao et al. (8 authors)
Frontiers in Cellular and Infection Microbiology Open Access
Published: Sep 2021
8 citations
18 days before retraction
Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
Sutpirat Moonmuang, Parunya Chaiyawat, Salinee Jantrapirom et al. (5 authors)
Cancers Open Access
Published: Aug 2021
14 citations
37 days before retraction
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis
Sujie Gao, Shengnan Ren, Yiting Liu et al. (5 authors)
Molecular Therapy — Oncolytics Open Access
Published: Jul 2021
39 citations
79 days before retraction
Comprehensive Analysis of Peritoneal Metastasis Sequencing Data to Identify LINC00924 as a Prognostic Biomarker in Gastric Cancer
Yan Fang, Sihao Huang, Lei Han et al. (5 authors)
Cancer Management and Research Open Access
Published: Jul 2021
42 citations
88 days before retraction
FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis
Yue Yang, Zhibo Sun, Feng Liu et al. (5 authors)
Cartilage Open Access
Published: Apr 2021
20 citations
171 days before retraction
Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
Wuping Yang, Jingcheng Zhou, Kenan Zhang et al. (10 authors)
Journal of Cancer Open Access
Published: Jan 2021
31 citations
269 days before retraction
Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1)
Yue Yang, Longqing Shi, Dong Zhang et al. (7 authors)
Bioengineered Open Access
Published: Jan 2021
17 citations
269 days before retraction
Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers.
Lixu Zhu, Xiaoyi Shi, Xiao Yu et al. (7 authors)
American Journal of Translational Research
Published: Jan 2021
9 citations
269 days before retraction
Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis
Fang Cui, Peng Luo, Yao Bai et al. (4 authors)
Technology in Cancer Research & Treatment Open Access
Published: Jan 2021
14 citations
269 days before retraction
Quick Stats
Total Citations: 17
Years Since Retraction: 4.2 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers